Pathways that contribute to TNF production by the kidney are not well defined. Mice given 1% NaCl in the drinking water for 3 days exhibited a 2.5-fold increase in urinary, but not plasma, TNF levels compared with mice given tap water. Since furosemide attenuated the increase in TNF levels, we hypothesized that hypertonic NaCl intake increases renal TNF production by a pathway involving the Na ϩ -K ϩ -2Cl Ϫ cotransporter (NKCC2). A 2.5-fold increase in NKCC2A mRNA accumulation was observed in medullary thick ascending limb (mTAL) tubules from mice given 1% NaCl; a concomitant 2-fold increase in nuclear factor of activated T cells 5 (NFAT5) mRNA and protein expression was observed in the outer medulla. Urinary TNF levels were reduced in mice given 1% NaCl after an intrarenal injection of a lentivirus construct designed to specifically knockdown NKCC2A (EGFP-N2A-ex4); plasma levels of TNF did not change after injection of EGFP-N2A-ex4. Intrarenal injection of EGFP-N2A-ex4 also inhibited the increase of NFAT5 mRNA abundance in the outer medulla of mice given 1% NaCl. TNF production by primary cultures of mTAL cells increased approximately sixfold in response to an increase in osmolality to 400 mosmol/kgH2O produced with NaCl and was inhibited in cells transiently transfected with a dnNFAT5 construct. Transduction of cells with EGFP-N2A-ex4 also prevented increases in TNF mRNA and protein production in response to high NaCl concentration and reduced transcriptional activity of a NFAT5 promoter construct. Since NKCC2A expression is restricted to the TAL, NKCC2A-dependent activation of NFAT5 is part of a pathway by which the TAL produces TNF in response to hypertonic NaCl intake. TNF; NFAT5; Ton/EBP; NKCC2; thick ascending limb; hypertonic stress TUMOR NECROSIS FACTOR-␣ (TNF) is produced by several cell types along the nephron including the medullary thick ascending limb of Henle's loop (mTAL), which reabsorbs ϳ25% of filtered NaCl and is the site of action for loop diuretics (12, 41). TNF acts in an autocrine manner to inhibit in vitro correlates of Na ϩ reabsorption by a mechanism involving induction of cyclooxygenase-2 (COX-2), and the contribution of this cytokine to renal function is still being defined (17). For instance, recent studies have shown that TNF exhibits natriuretic effects, exerts a tonic inhibitory effect on the Na ϩ -K ϩ -2Cl Ϫ cotransporter (NKCC2), and inhibits endothelial nitric oxide synthase expression in the TAL (2, 50, 53, 54) . The mTAL produces TNF in response to several stimuli; however, knowledge regarding the pathways that contribute to TNF production by the kidney is limited (1, 12, 18, 22, 41, 59 ).
Hao S, Bellner L, Ferreri NR. NKCC2A and NFAT5 regulate renal TNF production induced by hypertonic NaCl intake. Am J Physiol Renal Physiol 304: F533-F542, 2013. First published December 26, 2012; doi:10.1152/ajprenal.00243.2012.-Pathways that contribute to TNF production by the kidney are not well defined. Mice given 1% NaCl in the drinking water for 3 days exhibited a 2.5-fold increase in urinary, but not plasma, TNF levels compared with mice given tap water. Since furosemide attenuated the increase in TNF levels, we hypothesized that hypertonic NaCl intake increases renal TNF production by a pathway involving the Na ϩ -K ϩ -2Cl Ϫ cotransporter (NKCC2). A 2.5-fold increase in NKCC2A mRNA accumulation was observed in medullary thick ascending limb (mTAL) tubules from mice given 1% NaCl; a concomitant 2-fold increase in nuclear factor of activated T cells 5 (NFAT5) mRNA and protein expression was observed in the outer medulla. Urinary TNF levels were reduced in mice given 1% NaCl after an intrarenal injection of a lentivirus construct designed to specifically knockdown NKCC2A (EGFP-N2A-ex4); plasma levels of TNF did not change after injection of EGFP-N2A-ex4. Intrarenal injection of EGFP-N2A-ex4 also inhibited the increase of NFAT5 mRNA abundance in the outer medulla of mice given 1% NaCl. TNF production by primary cultures of mTAL cells increased approximately sixfold in response to an increase in osmolality to 400 mosmol/kgH2O produced with NaCl and was inhibited in cells transiently transfected with a dnNFAT5 construct. Transduction of cells with EGFP-N2A-ex4 also prevented increases in TNF mRNA and protein production in response to high NaCl concentration and reduced transcriptional activity of a NFAT5 promoter construct. Since NKCC2A expression is restricted to the TAL, NKCC2A-dependent activation of NFAT5 is part of a pathway by which the TAL produces TNF in response to hypertonic NaCl intake. TNF; NFAT5; Ton/EBP; NKCC2; thick ascending limb; hypertonic stress TUMOR NECROSIS FACTOR-␣ (TNF) is produced by several cell types along the nephron including the medullary thick ascending limb of Henle's loop (mTAL), which reabsorbs ϳ25% of filtered NaCl and is the site of action for loop diuretics (12, 41) . TNF acts in an autocrine manner to inhibit in vitro correlates of Na ϩ reabsorption by a mechanism involving induction of cyclooxygenase-2 (COX-2), and the contribution of this cytokine to renal function is still being defined (17) . For instance, recent studies have shown that TNF exhibits natriuretic effects, exerts a tonic inhibitory effect on the Na ϩ -K ϩ -2Cl Ϫ cotransporter (NKCC2), and inhibits endothelial nitric oxide synthase expression in the TAL (2, 50, 53, 54) . The mTAL produces TNF in response to several stimuli; however, knowledge regarding the pathways that contribute to TNF production by the kidney is limited (1, 12, 18, 22, 41, 59) .
Renal medullary tonicity modulates regulatory systems that control tubular and microcirculatory function in the kidney; the molecules involved in these processes are still being explored (51) . The rate of NaCl transport in the TAL is an important determinant of medullary hypertonicity, and the majority of this transport occurs via NKCC2 a 12-transmembrane-helix transport protein expressed exclusively in the apical membrane of the TAL and macula densa cells in the kidney (20, 29) . Reabsorption of NaCl is then completed as Na ϩ exits the cell via the basolateral Na ϩ -K ϩ -ATPase, while Cl Ϫ diffuses along its electrochemical gradient through basolateral KCl cotransporters or Cl Ϫ channels. Nuclear factor of activated T cells 5 (NFAT5) is a transcription factor that is essential for adaptation of the kidney to the hypertonic environment in the medulla (15, 31, 42) . NKCC2 and NFAT5 are sequentially expressed during renal development, and inhibition of NKCC2 activity by furosemide reduces expression of NFAT5 and its target genes in the renal medulla (36, 55) . NFAT5 abundance in the renal medulla was reduced in association with the downregulation of NKCC2 and Na ϩ -K ϩ -ATPase in response to hypokalemia (30) , and downregulation of NFAT5 may occur in response to reduced tonicity in the renal medullary interstitium (37) . Collectively, these studies implicate an important functional link between NKCC2 and NFAT5.
We recently identified NFAT5 as a predominant NFAT isoform in the mTAL and showed it is integral to TNF gene transcription induced by activation of the calcium sensing receptor (22) . We also showed that NKCC2 isoform A (NKCC2A) contributes to the regulation of NFAT5 in primary cultures of mTAL cells exposed to elevated NaCl concentration (23) . In the present study we determined if a pathway involving NKCC2A and NFAT5 contributes to renal TNF production in response to hypertonic NaCl intake.
EXPERIMENTAL PROCEDURES
Animals. Male C57BL/6J mice (8 -12 wk) purchased from Jackson Laboratory were maintained on standard diet and given either tap water or 1% NaCl in the drinking water ad libitum. Experimental procedures were conducted in accordance with New York Medical College IACUC approval and international guidelines for the welfare of animals (animal welfare assurance no. A3362-01, Office of Laboratory Animal Welfare, Public Health Service, National Institutes of Health). Mice were placed in metabolic cages under conditions of constant temperature and humidity with a 12:12-h light-dark cycle and allowed to adapt to these conditions for several days before starting any procedures. Furosemide was dissolved in 50% dimethyl sulfoxide, pH 7, and then injected subcutaneously at a dose of 30 mg·kg Ϫ1 ·day Ϫ1 . Mice were pretreated with furosemide for 1 day before ingestion of 1% NaCl in the drinking water for 3 days in the presence of daily furosemide treatment.
Chemicals and reagents. The anti-NFAT5 antibody was purchased from Santa Cruz Biotechnology (Santa Cruz, CA) and used at 1:1,000 dilution for immunoblot analysis. The antibody for NKCC2 (Chemi-con) was used at a 1:3,000 dilution; the antibody for enhanced green fluorescent protein (EGFP; Abcam) was used at a 1:10,000 dilution. Tissue culture media were obtained from Life Technologies (Grand Island, NY). Collagenase (type 1A) was from Sigma-Aldrich (St. Louis, MO), and polyvinylidene difluoride membranes were obtained from Amersham (Arlington Heights, IL). The luciferase assay kit was from Promega (Madison, WI).
Isolation of mTAL tubules and cells. mTAL tubules and cells (90 -95% purity) were isolated from mice as previously described (23) . Briefly, male C57BL/6J mice were anesthetized with an intraperitoneal injection of pentobarbital (6.5 mg/kg body wt). The kidneys were perfused with sterile 0.9% saline via retrograde perfusion of the aorta, removed, and cut along the corticopapillary axis. The outer medulla was excised, minced with a sterile blade, and incubated for 10 min at 37°C in a 0.01% collagenase solution gassed with 95% oxygen. The suspension was sedimented on ice and mixed with HBSS containing 2% BSA, and the supernatant containing the crude suspension of tubules was collected. The collagenase digestion step was repeated three times; the remaining undigested tissue and the combined supernatants were centrifuged for 10 min, resuspended in HBSS, and filtered through a 53-m nylon mesh membrane (Fisher Scientific, Springfield, NJ). The filtered solution was discarded, and tubules retained on the mesh were resuspended in HBSS and centrifuged at 500 rpm for 10 min; pelleted tubules were used in experiments or to establish primary cultures of mouse mTAL cells. Cells were grown on membrane inserts in six-well plates using renal epithelial cell basal medium (REBM; Cambrex), containing renal epithelial cell growth medium (REGM; Cambrex) consisting of rhEGF, insulin, hydrocortisone, GA-1000 (gentamycin sulfate and amphotericin B), FBS, epinephrine, T3 (triiodothronine), and transferrin. After 6 -7 days, monolayers of cells were 70 -80% confluent. The cells were quiesced for 24 h in RPMI containing 0.42 mM CaCl 2 and 0.5% FBS, L-glutamine (2 mM), 100 U/ml streptomycin/penicillin (GIBCO), MEM nonessential amino acids (GIBCO), MEM sodium pyruvate, and ␤-mercaptoethanol before their use (59) .
Plasmid constructs and virus preparation. All constructs were generated using standard cloning procedures and verified by restriction enzyme analysis and DNA sequencing. A NFAT5-dominant negative (NFAT5-DN) expression plasmid was generated by cloning a NFAT5 cDNA fragment containing the NFAT5 DNA binding domain (DBD) into pcDNA3.1 vector (Invitrogen); a cDNA (nucleotides 1074 -1694) encoding amino acids 175-471 (NM_018823.1) was used in this study (22) . The cDNA was amplified from the pBluescript SK ϩ vector containing full-length NFAT5 using restriction enzymes BamHI and XhoI and ligated into pcDNA3.1 vector. The pTonE_Luc reporter (57) (originally from Dr. Steffan N. Ho), was provided by Dr. Feng Cheng, Washington University (St. Louis, MO). The inhibitory construct for NKCC2A was designed using an short hairpin (sh)RNA-expressing construct targeting exon 4 of murine NKCC2A (U6-N2A ex4) under control of the murine U6 small nuclear (sn)RNA promoter as described previously (13, 23) ; scrambled U6-shRNA (U6) was used as a negative control. Subcloning of EGFP or EGFP-N2A-ex4 into a pLKO.1 vector and cotransfecting HEK293-T cells with pLKO.1 were performed to generate lentivirus encoding EGFP or EGFP-N2A-ex4. psPAX2 and pMD2.G plasmids were used for preparation of lentivirus (Addgene MIT, Cambridge, MA).
Gene transduction. HEK293-T cells were grown in 20-cm 2 flasks to generate lentivirus. Briefly, the packaging cells were seeded at a density of 7 ϫ 10 5 cells per flask in 5 ml media (DMEM/10% FBS/no antibiotics) 24 h before transfection and grown at 37°C/5% CO2. DNA for transfection was prepared by mixing 1.0 g psPAX2 and 0.1 g pMD2.G with 1.5 g pLKO.1 or psiLV plasmids in each flask. A mixture of 150 l OptiMEM (GIBCO) and 6 l FUGENE (Roche) was then added to the DNA, and this mixture was incubated for 15 min before adding to the packaging cells. Cells were incubated for 12 h, and the media were changed to remove remaining transfection reagent. Lentiviral supernatants were collected 48 h after transfection, and the supernatants were pooled, filter purified with Lenti-X Maxi purification kit (cat. no. 631234; Clontech), and then frozen at Ϫ80°C for long-term storage.
Primary cultures of murine mTAL cells were cultured to 70 -80% confluence in 6-well plates with membrane inserts (cell culture inserts; BD Biosciences) as indicated (10), the medium was removed, and the cells were placed in 1 ml of serum-free OPTI-MEM medium containing different plasmid DNA constructs and 10 l Lipofectamine 2000 (Invitrogen), according to the manufacturer's instructions, for 4 h at 37°C/5% CO2. After the transfection period, 1 ml of REGM containing 20% FBS was added, and the cells were incubated overnight at 37°C/5% CO2. The medium was then removed, and the cells were cultured for an additional 12-48 h in REGM containing 10% FBS. Transfection efficiency was evaluated by flow cytometry as described previously (22) .
Gene transfer in vivo. Mice were anesthetized with 100 mg/kg ketamine-20 mg/kg xylazine (ip). In anesthetized mice, a 31-G needle was inserted at the lower pole of the left kidney parallel to the long axis and was carefully pushed toward the upper pole. As the needle was slowly removed, 100 l filter-purified lentivirus (EGFP or EGFP-N2A-ex4 ϳ5 ϫ 10 7 transducing units) were injected. Preliminary studies showed that lentiviral-mediated EGFP DNA and protein expression in kidney parenchyma were robust after 72 h, and no toxicity was observed in mice treated with the lentiviral vector as survival was not affected in lentivirus-injected or PBS-injected animals.
Morphology and immunohistochemistry. The outer medulla was cut into small segments and fixed in 4% paraformaldehyde overnight. Tissues were transferred to well plates and, after removal of the solution, were preserved for 6 h in 30% sucrose and embedded in OCT or stored at Ϫ80°C. Sections were cut at 20-m thickness and dried for 30 min at 37°C. Outer medullary tissue also was embedded in paraffin, and 3-m sections were stored in neutral buffered formalin for 48 h; deparaffinization was performed according to a standard protocol. Slides containing cryostat or paraffin sections were visualized using a Nikon Microphot FXA microscope equipped for epifluorescence illumination or used for immunostaining experiments. Briefly, multiple sections were first incubated in a blocking solution consisting of PBS with 1% BSA for 1 h in a humidified chamber at room temperature. The sections were incubated with anti-EGFP polyclonal rabbit antibody (1:500 dilution; Abcam) and secondary antibody diluted 1:10,000 in PBS (donkey anti-rabbit-conjugated with Alexa Fluor 488; Invitrogen). Primary antibody was excluded and replaced by PBS as a negative control.
Measurement of TNF. The TNF content in 100 l of cell-free supernatants, urine, or plasma was determined in duplicate by ELISA (Pharmingen), as previously described (59) .
Isolation of total RNA and amplification of cDNA fragments. Total RNA was isolated from mouse mTAL tubules and primary cultures of mTAL cells by addition of 1 ml Tri-Zol reagent. Chloroform (0.2 ml) was then added at room temperature for 2-3 min followed by centrifugation at 4°C at 12,000 rpm for 15 min. Isopropanol (3 vol) was added to the recovered supernatant and the mixture incubated at room temperature for 10 min and then centrifuged at 4°C at 12,000 rpm for 15 min. The supernatant was discarded, the pellet washed in 1 ml of 75% EtOH, mixed gently, and centrifuged for 5 min at 7,500 rpm at 4°C; the supernatant was removed, and the pellet was dried for 5-10 min. Finally, the RNA pellet was resuspended in 50 l of RNase free dH2O and stored at Ϫ70°C. After total RNA was treated with deoxyribonuclease I for 30 min, a 3-g aliquot was used for cDNA synthesis using the Superscript Preamplification System (Life Technologies) in a 20 l reaction mixture containing Superscript II reverse transcriptase (200 U/l) and random hexamers (50 ng/l). The reaction was incubated at room temperature for 10 min to allow extension of the primers by reverse transcriptase and then at 42°C for 50 min, 70°C for 15 min, and 4°C for 5 min. cDNA fragments were size fractionated on a 1% agarose gel and stained with ethidium bromide.
Quantitative real-time reverse transcription-PCR analysis. A 0.5-g aliquot of total RNA was converted to cDNA using random primers and PowerScript RT (Clontech). The cDNA from each RNA sample was placed in a 20 l RT-PCR mixture using a FastStart DNA Master SYBR Green I kit (Roche) supplemented with 3 mM MgCl 2 and Platinum Taq polymerase (Invitrogen). Quantitative real-time PCR (qRT-PCR) was used to determine the accumulation of mRNA. The specific primer pairs for murine NFAT5, NKCC2A, NKCC2F, TNF, and EGFP are provided in Table 1 . Input cDNAs were normalized using the housekeeping gene ␤-actin, and the efficiency of primer pair amplification was determined from a standard curve generated using protocols described previously (48, 49) . The 2( ⌬⌬Ϫ CT) method was used to evaluate changes in mRNA accumulation (38) .
NFAT5 protein and reporter assay. Nuclear extracts were prepared by a modification of the method of Dignam et al. (6) . One day after transfection, cells were quiesced overnight in RPMI medium containing 0.5% FBS and treated with appropriate reagents for the indicated times. After treatment, cells were harvested with RIPA buffer into 1.5-ml Eppendorf tubes and spun for 5 min at 4,000 rpm and 4°C. The cell pellets were lysed in CE buffer (10 mM Tris, pH 8.0, 60 mM KCl, 2 mM MgCl 2, 1 mM DTT, 0.1 mM EDTA, 0.5 mM PMSF, 10 g/ml aprotinin, 25 M leupeptin, 2 M pepstatin A, and 0.3% Nonidet P-40 at 4°C) and centrifuged for 5 min at 4,000 rpm and 4°C. The nuclei were kept on ice and washed in 0.5 ml CE buffer without Nonidet P-40 for 5 min at 4,000 rpm. Nuclear proteins were extracted under high-salt conditions in a solution containing 20 mM Tris, pH 7.8, 0.42 M NaCl, 1.5 mM MgCl 2, 0.5 mM DTT, 0.2 mM EDTA, 0.5 mM PMSF, 10 g aprotinin per ml, 25 M leupeptin, 2 M pepstatin A, and 25% (vol/vol) glycerol for 30 min at 4°C. After centrifugation at 12,000 rpm for 30 min, the protein concentration in the supernatant was determined with a Bio-Rad protein assay kit. In the NFAT5 reporter assay experiments, cells were transfected using DEAE-dextran with luciferase reporter plasmids (1 g) and TK-Renilla (0.6 g), together with different plasmid constructs (7 g) or corresponding empty plasmid vector (pcDNA3.1). The luciferase activities of cell extracts were determined using a Dual-Luciferase Reporter Assay System (Promega). Luciferase activity was calculated as relative light units from reporter luciferase normalized to R. reniformis luciferase values.
Western blot analysis. Tissues were solubilized with sucrose isolation buffer for total NKCC2 (7) or lysis buffer [0.4 M NaCl, 0.5 mM EGTA, 1.5 mM MgCl 2, 10 mM HEPES, pH 7.9; 5% (vol/vol) glycerol, and 0.5% (vol/vol) Nonidet P-40] for NFAT5 and EGFP after protease inhibitors (Roche Diagnostics) were added. Protein concentration was determined with a Bio-Rad protein assay kit. The samples were heated at 60°C in loading buffer, and equal amounts of protein were separated by SDS-PAGE and transferred to nitrocellulose membranes. Following blocking at room temperature for 1 h with 5% skim milk, membranes were probed at 4°C overnight with appropriate primary antibodies, followed by incubation with horseradish peroxidase-conjugated secondary antibodies (Amersham Pharmacia Biotech). Membranes were washed, and proteins were detected by enhanced chemiluminescence (ECL; Amersham, Arlington Heights, IL).
Statistics. All data are presented as mean Ϯ SE. Statistical analyses were performed using one-way ANOVA followed by Tukey's multiple comparisons test and unpaired t-test as appropriate GraphPad Prism software (GraphPad Software, San Diego, CA). Differences with P Ͻ 0.05 were considered statistically significant.
RESULTS
Hypertonic NaCl intake increases NKCC2A but not NKCC2F mRNA accumulation. Specific primer pairs for murine NKCC2A and NKCC2F were designed using Epicentre software according to the cDNA sequences of mutually exclusive cassette exons A and F for mouse NKCC2 isoforms ( Table 1 ). The relative abundance of mRNA levels for NKCC2A increased more than twofold in outer medulla from mice given 1% NaCl in the drinking water for 3 days compared with mice given tap water (Fig. 1A) . In contrast, NKCC2F mRNA accumulation did not change in response to an increase in NaCl intake (Fig.  1B) . Similarly, NKCC2A but not NKCC2F mRNA accumulation increased in freshly isolated mTAL tubules from mice given 1% NaCl for 3 days (Fig. 1, C and D) . Collectively, these data indicate that hypertonic NaCl (HS) intake selectively increases NKCC2A mRNA accumulation in the outer medullary TAL. In control experiments, total RNA was amplified before cDNA synthesis to exclude possible contamination with genomic DNA; DNA sequences for each of the PCR fragments derived from outer medulla were identical to those previously published for the corresponding NKCC2 isoforms (not shown).
HS intake increases NFAT5 mRNA and protein expression. The effects of HS intake, which increases medullary tonicity (26), on outer medullary NFAT5 expression were then determined. Results from qRT-PCR experiments show that NFAT5 mRNA accumulation increased about twofold in mice given 1% NaCl in the drinking water for 3 days (Fig. 2A ). An increase in NFAT5 protein expression also was observed after mice were given 1% NaCl for 3 days (Fig. 2B) . These data raise the possibility that increases in NFAT5 in response to HS intake may be linked to increases in NKCC2A.
Determination of transgene expression with intrarenal lentivirus injection. Lentiviral transduction of outer medulla was established to evaluate a possible functional link between NKCC2A and NFAT5 in vivo. Direct renal injection was performed on mice given a single injection of PBS or lentiviral vectors containing a CMV promoter to drive expression of the EGFP gene. All mice survived 72 h after PBS or lentiviral vectors were injected into their kidneys, at which time animals were euthanized and kidneys harvested and snap frozen to analyze EGFP expression in outer medulla. Specific EGFP DNA and protein bands were detected in mice injected with empty virus (EGFP-U6) and NKCC2A targeting virus (EGFP-N2A-ex4; Fig. 3, A and B) . The detection of EGFP by fluorescence microscopy proved particularly difficult in the kidney because of high background fluorescence. To circumvent this obstacle, we analyzed EGFP expression by immunohistochemistry using a specific anti-EGFP polyclonal rabbit antibody.
Specific staining for EGFP was observed in outer medulla and mTAL tubules following the direct renal injection of the lentivirus but not in control kidneys from mice injected with PBS (Fig3C). The data show that intrarenal delivery of lentivirus resulted in a robust expression of EGFP in the outer medulla and mTAL tubules harvested 72 h after injection.
Knockdown of NKCC2A in vivo. We recently developed a specific shRNA construct to target NKCC2A in cultured mouse mTAL cells (23) . In the present study, the NKCC2A shRNA construct was cloned into a vector that also encoded EGFP, to allow visualization as illustrated in Fig. 3C . The efficacy for this new lentivirus vector (EGFP-N2A-ex4) in vivo was evaluated in outer medulla 3 days after mice were injected with EGFP-N2A-ex4 or empty vector (EGFP-U6). A 200-bp cDNA fragment was amplified by RT-PCR and sequenced to confirm the identity of NKCC2A by NCBI BLAST (Fig. 4, A and B) . Analysis using qRT-PCR revealed that injection of EGFP-N2A-ex4 inhibited NKCC2A mRNA levels by ϳ60% (Fig.  4C ). The effect of NKCC2A knockdown on total NKCC2 expression was determined by Western blot analysis of outer medulla from mice given 1% NaCl in drinking water for 3 days. The data show that injection of the lentivirus targeting NKCC2A (EGFP-N2A-ex4) significantly inhibited total NKCC2 protein expression in outer medulla (Fig. 4, D and E) .
Induction of NFAT5 mRNA levels in response to HS intake is dependent on NKCC2A. Freshly isolated mTAL tubules were obtained 3 days after mice were injected with EGFP-N2A-ex4 or empty vector (EGFP-U6) and then given 1% NaCl for an additional 3 days. The data show that injection of EGFP-N2A-ex4 abolished the increase of NFAT5 mRNA abundance in mTAL tubules isolated from mice given 1% NaCl; baseline levels of NFAT5 were not affected (Fig. 5A) . In contrast, in vivo knockdown of EGFP-N2A-ex4 had no effect on NKCC2F mRNA levels (Fig. 5B) , a finding consistent with Fig. 3 . Detection of enhanced green fluorescent protein (EGFP) transgene expression in lentivirus-transduced kidneys. Outer medullary tissue or mTAL tubules were collected from kidneys injected with lentivirus as described in EXPERIMENTAL PROCEDURES. A: total DNA was extracted and PCR amplification for EGFP was performed using primers in Table 1 . B: Western blot analysis of EGFP expression in outer medulla from mice injected with EGFP-N2A-ex4, PBS (CTRL), and EGFP-U6. C: visualized expression of EGFP in lentiviral-transduced sections prepared from outer medulla or mTAL tubules collected 3 days following lentiviral or control injections. A-C are presented as representative of at least 3-6 individual experiments. results obtained using these constructs in cultured mTAL cells (23) . These results indicate that EGFP-N2A-ex4 specifically silences NKCC2A in vivo and suggest that NKCC2A is part of a pathway that enhances NFAT5 expression in the TAL in response to intake of hypertonic NaCl.
Renal TNF production in vivo is dependent on NKCC2A. We previously showed that NFAT5 is involved in calcium sensing receptor-dependent TNF production in mTAL cells (22) . As NKCC2A is part of a pathway that regulates NFAT5 in cultured mTAL cells (23) and in vivo (Fig. 5) , the effect of silencing NKCC2A on in vivo levels of TNF was determined in urine and plasma 3 days after mice were injected with EGFP-N2A-ex4 or empty vector (EGFP-U6) and then given 1% NaCl for an additional 3 days. Ingestion of 1% NaCl increased TNF levels in urine but not plasma, suggesting a specific effect of HS intake on TNF production by the kidney (Fig. 6, A and C) . Urinary levels of TNF remained elevated in mice injected with control lentivirus encoding EGFP-U6 (40.3 ϩ 2.5 pg/24 h). However, urinary TNF levels were inhibited in mice injected with EGFP-N2A-ex4 (24.5 ϩ 2.2 pg/24 h; Fig. 6A ). Urinary TNF levels also were reduced in mice injected with furosemide and given 1% NaCl for 3 days, suggesting that the reduction in renal TNF production after knockdown of NKCC2A is related to reduced availability of total NKCC2A protein (Fig. 6B) . As expected, the inhibitory effect of EGFP-N2A-ex4 was limited to the kidney as no changes in plasma TNF levels were observed (Fig. 6C) . Moreover, knockdown of NKCC2A did not affect basal levels of urinary TNF, suggesting that this isoform is specifically enabled to participate in the response of the kidney to HS intake (Fig. 6D) . Overall, the data suggest that a significant portion of renal TNF production in response to HS intake is derived from the TAL and is NKCC2A dependent.
TNF production in mTAL cells is dependent on NKCC2A. Primary cultures of mTAL cells were transduced with lentivirus packaged with the shRNA vector targeting NKCC2A (EGFP-N2A-ex4) to directly evaluate the role of NKCC2A on A: cDNA fragments for NKCC2A isoform from were generated by RT-PCR from outer of medulla of control mice (Ϫ) and mice injected with EGFP-N2A-ex4 (ϩ). B: validation of NKCC2A isoform specificity using cDNA sequences generated using total RNA in outer medulla. C: qRT-PCR analysis of specific knockdown of NKCC2A isoform mRNA in outer medulla after renal injection of the EGFP-N2A-ex4 lentivirus construct for 3 days as described in EXPERIMENTAL PROCEDURES. D: representative Western blot. E: analysis of total NKCC2 protein expression in outer medulla from mice given 1% NaCl in drinking water for 3 days after renal injection of EGFP-N2A-ex4 lentivirus. Data are presented as mean values Ϯ SE (n ϭ 6). Fig. 5 . Effects of NKCC2A isoform knockdown on NFAT5 and NKCC2F mRNA abundance in vivo. NFAT5 (A) and NKCC2F (B) mRNA abundance was analyzed by qRT-PCR of total RNA prepared from mTAL tubules 3 days after mice were injected with EGFP-N2A-ex4 or empty vector and then given 1% NaCl for an additional 3 days. Data represent mRNA fold-change; means Ϯ SE; n ϭ 6. TNF production. Cells were quiesced overnight and then challenged with media made hypertonic by addition of NaCl, to a final concentration of 400 mosmol/kgH 2 O, after transduction with EGFP-N2A-ex4 or EGFP-U6. High NaCl concentration increased TNF mRNA and protein levels in uninfected cells and cells infected with control (EGFP-U6) lentivirus construct (Fig. 7, A and B) . In contrast, both TNF mRNA levels and the amount of TNF released from mTAL cells were markedly diminished in cells infected with the EGFP-N2A-ex4 vector (Fig. 7, A and B) . Inhibition of NKCC2 activity with bumetanide also inhibited the increase in mTAL cell TNF mRNA accumulation induced by a high concentration of NaCl (Fig.  7C) . These data are consistent with the in vivo data showing that furosemide inhibits renal production of TNF (Fig. 6B) and suggest that mTAL cells produce TNF in response to hypertonic NaCl intake via a mechanism involving the activity of NKCC2A.
NKCC2A-dependent regulation of NFAT5 activity in vitro. We previously showed that NKCC2A contributes to the regulation of NFAT5 transcriptional activity and protein expression (23) . However, since a novel lentivirus vector targeting NKCC2A was developed for the in vivo experiments in the present study, NFAT5 transcriptional activity was evaluated in mTAL cells to verify the efficacy of the new construct. The data show that NFAT5 transcriptional activity (TonE-Luc activity) increased after untransduced cells or cells transduced with empty vector (EGFP-U6) were challenged with NaCl (400 mosmol/kgH 2 O) for 9 h (Fig. 8) . However, NFAT5 activity was markedly attenuated in mTAL cells when EGFP-N2A-ex4 was used to specifically knockdown NKCC2A (Fig. 8) . These data are consistent with those in our previous study and show that a significant portion of NFAT5 transcriptional activity is regulated by NKCC2A in mTAL cells exposed to a high NaCl concentration.
Inhibition of NFAT5 blocks HS-induced TNF production by mTAL cells.
We determined if TNF produced in response to hypertonic NaCl is dependent on NFAT5 activation in mTAL cells. An NFAT5-DN expression plasmid was constructed by cloning a NFAT5 cDNA fragment into pcDNA3.1 vector, as previously described (13, 22) . Transient transfection with NFAT5-DN, but not empty vector, abolished TNF production induced by high NaCl concentration (400 mosmol/kgH 2 O) for 9 h, suggesting that NFAT5 plays an essential role in induction of TNF production by mTAL cells exposed to hypertonic NaCl (Fig. 9) .
DISCUSSION
We demonstrated that TNF production by the kidney increases in response to hypertonic NaCl intake. Moreover, the TAL is an important source of TNF production by the kidney as NKCC2A contributes to a pathway, involving activation of NFAT5, that promotes TNF production by this segment of the nephron. Increases in NKCC2A mRNA and NFAT5 mRNA levels and NFAT5 protein expression were observed in mice given 1% NaCl in the drinking water. Renal injection of a specific lentivirus-targeting vector (EGFP-N2A-ex4) attenuated expression of NKCC2A mRNA in response to hypertonic NaCl intake and prevented increases in NFAT5 and urinary TNF without affecting either plasma levels of TNF or NKCC2F mRNA levels. Silencing of NKCC2A also inhibited NFAT5 transcriptional activity and TNF production in primary cultures of mTAL cells, as did transient transfection with a dominant negative NFAT5 construct. The present study illustrates that NKCC2A, but not NKCC2F mRNA accumulation, is upregulated in the TAL in response to hypertonic NaCl intake, supporting the view that a pathway involving NKCC2A-dependent enhancement Fig. 6 . Effects of NKCC2A isoform knockdown on TNF production in vivo. TNF was measured by ELISA in urine and blood collected 3 days after mice were injected with EGFP-N2A-ex4 or empty vector and then given 1% NaCl for an additional 3 days (A and C). B: effects of furosemide treatment on urinary TNF levels measured 3 days after mice ingested tap water or 1% NaCl. D: measurement of urinary TNF levels in control mice that were injected with EGFP-N2A-ex4 or empty vector. Data are presented as mean values Ϯ SE (n ϭ 6).
of NFAT5 activity facilitates TNF production in this region of the kidney.
TNF is produced by the mTAL in response to a variety of stimuli including lipopolysaccharide, angiotensin II, and calcium receptor activation (12, 18, 41, 59 ). This cytokine acts via an autocrine mechanism to inhibit sodium transport in mTAL cells and is an endogenous inhibitor of NKCC2A mRNA accumulation, total NKCC2 expression, and NKCC2 activity (2, 12, 22) . These findings are consistent with studies showing that TNF causes marked polyuria and natriuresis in vivo (53, 54, 58) . Moreover, the defect in urine concentrating ability in conditions such as sepsis is associated with TNF-mediated downregulation of NKCC2 and other ion transporters in the kidney (52) , and acute renal failure, mediated in part by TNF (5) , is associated with decreases in major transporters (33, 52) . It is noteworthy that the increase in TNF production following hypertonic NaCl intake was restricted to the kidney as increases in plasma levels of TNF are generally observed in conditions where the proinflammatory actions of this cytokine contribute to the progression of pathological dysfunction. For instance, increases in plasma TNF levels are observed in pregnancy-induced hypertension and following administration of a high-salt diet to salt-sensitive Dahl-SS rats (21, 34) . In contrast, TNF does not increase blood pressure in normal rats and administration of 1% NaCl in the drinking water for 7 days was not associated with an increase in blood pressure (24, 26) . Overall, these findings are consistent with the emerging concept that TNF functions in a context-dependent manner as either a mediator or attenuator of renal damage. Accordingly, we postulate that controlled local production of TNF supports regulatory functions in the kidney, whereas increases in the peripheral circulation and in models of renal inflammation are associated with proinflammatory activities of this cytokine (9, 11, 28, 32, 44) . Furosemide or bumetanide, which inhibit Fig. 7 . NKCC2A isoform contributes to TNF production by mTAL cells. A: total RNA from primary mTAL cells grown on membrane inserts in 6-well plates and challenged with media made hypertonic by addition of NaCl, to a final concentration of 400 mosmol/kgH2O, for 4 h after transduction with EGFP-N2A-ex4 or control vector (EGFP-U6) was analyzed by qRT-PCR. Data represent mRNA fold-change relative to untreated cells. B: primary mTAL cells were challenged with NaCl (400 mosmol/kgH2O) for 9 h after transduction with EGFP-N2A-ex4 or control vector (EGFP-U6). TNF level in cell-free supernatants was determined by ELISA. C: mTAL cells were challenged with NaCl (400 mosmol/kgH2O) for 9 h after pretreatment with bumetanide; TNF levels in cell-free supernatants were determined by ELISA. Data are presented as mean values Ϯ SE (n ϭ 6). Fig. 8 . NKCC2A is part of a pathway in mTAL cells that increases NFAT5 activity. Primary mTAL cells were challenged with NaCl (400 mosmol/ kgH2O) for 9 h after cells were transduced with pTonE-Luc, pRL-TK, and EGFP-N2A-ex4 or EGFP-U6 lentivirus constructs. TonE-luciferase activity was determined and normalized using corresponding Renilla reniformis luciferase activity. Values are means Ϯ SE expressed as fold change relative to untreated cells; n ϭ 6. Fig. 9 . TNF production is dependent on NFAT5 activity induced by high NaCl. Primary mTAL cells were incubated in the absence or presence of NaCl (400 mosmol/kgH2O) for 9 h following transfection with a dominant negative NFAT5 (NFAT5-DN) or empty plasmid vector (pcDNA3.1). Supernatants were harvested, and TNF concentrations were determined by ELISA. Values are means Ϯ SE; P Ͻ 0.05; n ϭ 6. NKCC2 activity and subsequent NFAT5 activation, decreased TNF production by the TAL (23, 55) . Furosemide has been shown to increase NKCC2 protein expression, and our recent study showed an increase in NKCC2 protein expression and activity in the TAL of TNF-deficient mice (2, 8) . Collectively, these findings support the notion that TNF acts as a negative feedback regulator of NKCC2.
Both in vivo and in vitro experiments illustrated that NKCC2 activity contributes to TNF production by the kidney and cultured mTAL cells. NKCC2 is expressed specifically in the apical membrane of TAL and macula densa cells, and several studies have described the distribution and function of three major alternatively spliced isoforms termed NKCC2A, NKCC2B, and NKCC2F (4, 29, 43, 45, 46) . As the NKCC2A and F isoforms are expressed in the mTAL, the effect of hypertonic NaCl intake was evaluated on these isoforms. Moreover, a selective increase of NKCC2A mRNA in mTAL cells exposed to high NaCl concentration (23) prompted the present study to determine if administration of 1% NaCl in the drinking water, which increases medullary interstitial osmolality to ϳ400 mosmol/kg H 2 O (26), increases TNF production by the kidney via a pathway involving NKCC2A. Indeed, an increase in NKCC2A mRNA accumulation was observed in mTAL tubules isolated from mice that received 1% NaCl whereas NKCC2F mRNA levels did not change. In addition, silencing of NKCC2A reduced renal TNF production to an extent similar to that observed when NKCC2 activity was inhibited by furosemide or bumetanide. These findings suggest that NKCC2 activity is important in the adaptation of the kidney to high NaCl intake; the view that NKCC2A acts as a NaCl-sensitive alternative splice product that regulates TAL cell function in response to hypertonic stress will be addressed in future studies. The essential role of NKCC2 in establishing the medullary interstitial gradient is evident in studies using NKCC2 Ϫ/Ϫ mice, which exhibit a lower ambient urinary osmolality than their WT littermates (56) . A reduction in ambient urine osmolality also was observed in NKCC2A-deficient mice (46) . We recently demonstrated a selective elevation of NKCC2A mRNA accumulation in TNF Ϫ/Ϫ mice, which was accompanied by an increase in NKCC2 activity in mTAL tubules and an increase in ambient urine osmolality, and suggested that the absence of TNF contributes to the increased interstitial gradient generated by elevated NKCC2A expression and activity (2) .
Previous work from our laboratory identified NFAT5 as a predominant NFAT isoform in the mTAL and showed it is integral to activation of TNF gene transcription in mTAL cells (22) . Although NFAT5 contributes importantly to cellular protective mechanisms in response to hyperosmotic stress via induction of genes encoding for organic osmolytes, the role of additional target genes in the kidney downstream of NFAT5 remains to be determined. The functional link between NKCC2 activity and NFAT5 described in the present study is consistent with previous work showing that infusion of furosemide by osmotic minipump, which resulted in a decrease in medullary tonicity, was associated with blunted expression of TonEBP/ (NFAT5) (55) . Thus induction of an NKCC2A-mediated NFAT5 transcriptional mechanism may factor into the integrated response of the TAL to changes in the composition of the tubular fluid. As increased NaCl delivery to the TAL after oral saline loading has been associated with an increase in net NaCl reabsorption and NKCC2 expression in this segment (8, 35) , upregulation of NKCC2A may be part of an adaptive/ protective mechanism involving NFAT5, based on the established protective role of this transcription factor in the kidney (3, 15) . Moreover, elevation of NKCC2A in response to hypertonic NaCl intake is consistent with the finding that, under conditions of increased extracellular osmolality, NKCC2 functions as the major salt transport pathway in the TAL (19) . It is important to recognize that an elevation in NaCl intake increases tubular flow axially, a phenomenon linked to induction of superoxide and nitric oxide production in the TAL as well as induction of other important regulatory mechanisms along the nephron (16, 27, 47) . Interestingly, approximately half of the increase in NADPH oxidase-dependent superoxide production by the TAL was attributed to transport of NaCl by NKCC2 (27) , which is similar to the degree that NKCC2 activity contributes to TNF production.
The present study identifies NKCC2A as an upstream component in a pathway that regulates NFAT5-dependent renal TNF production in response to hypertonic NaCl intake. A self-limiting increase in NaCl transport in response to increasing osmolality has been reported in the mouse and rabbit TAL (14, 25) . Interestingly, NFAT5 binds to the TNF promoter in a manner distinct from other NFAT family members and is also a key regulator of TNF gene transcription during hypertonic stress in nonrenal cell types (13, 39, 40) . Heterogeneity of NaCl transport along the TAL may be related to specific functions mediated by NKCC2 isoforms (19) . For instance, the high transport capacity of the NKCC2A isoform coupled with its inducibility in response to hypertonic NaCl intake may necessitate a coupled mechanism that offsets an increase in NaCl transport. Future experiments will determine if TNF participates in a negative feedback pathway involving NKCC2A-dependent activation of NFAT5 that limits damage to the renal medulla when subjected to hypertonic stress.
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